ChemDiv works with Key Opinion Leaders (KOLs) in various therapeutic areas to develop clinical development plans for drug candidates. KOLs and consultants provide essential guidance in the design of protocols, selection of sites and choice of primary endpoints.
We work closely with world-known respected scientists:
Prof. Vladimir Kukes (Regilatory. Pre-Clinical/Early Clinical) Director of Clinical Pharmacology institute
Dr. Vera Belolipetskaya (Regilatory. Pre-Clinical/Early Clinical) Conducted >200 Phase I and bioequity studies
Prof. Michael Manns (Antiviral) Hannover School of Medicine, Germany
Prof. Aleksey Mazus (Antiviral) Director of Moscow Center for HIV Prevention
Prof. Aleksander Tiganov (CNS) Director of National Scientific Center of Mental Health, Principal Psychiatrist of Russian Ministry of Health.
Prof. Yury Aleksandrovsky (CNS) Deputy Head of Moscow Serbsky Institute of Social and Forensic Psychiatry
Prof. Segey Tyulyandin (Oncology) Deputy Director of Institute of Clinical Oncology (Blokhin’s Oncocenter)
Dr. Christoph Seeger (Flaviviruses) Fox Chase Cancer Center, Philadelphia
Dr. Francis Chisari (Virology) Scripps Clinic, San Diego
Dr. Ruben Donis (Influenza drug discovery) CDC, Atlanta
Dr. Margarita A. Morozova (Psychopharmacology) Head of Laboratory of Psychopharmacology, Russian Academy of Mental Health Research Center
Clinical Development 
